Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial

BACKGROUND: Liquid biopsy based on cell-free DNA circulating in plasma has shown solid results as a non-invasive biomarker. In the present study we evaluated the utility of circulating free DNA (cfDNA) and the sub-type tumor DNA (ctDNA) in hepatocellular cancer (HCC) patients to assess therapy respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alunni-Fabbroni, Marianna, Rönsch, Kerstin, Huber, Thomas, Cyran, Clemens C., Seidensticker, Max, Mayerle, Julia, Pech, Maciej, Basu, Bristi, Verslype, Chris, Benckert, Julia, Malfertheiner, Peter, Ricke, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771167/
https://www.ncbi.nlm.nih.gov/pubmed/31570105
http://dx.doi.org/10.1186/s12967-019-2079-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771167/
https://www.ncbi.nlm.nih.gov/pubmed/31570105
http://dx.doi.org/10.1186/s12967-019-2079-9

Ejemplares similares